Skip to main content

How does Nexavar work? Is it a chemo drug?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Feb 14, 2025.

Official Answer by Drugs.com

Nexavar is an oral cancer drug that is thought to work by blocking certain proteins inside and on the surface of the cancer cell. It also helps to prevent the growth of new blood vessels that help to “feed” the tumor’s growth. This may help kill the cancer cell and keep it from growing and spreading.

Nexavar (sorafenib) is used in adults to treat:

It is classified as a vascular endothelial growth factor (VEGF) inhibitor and tyrosine kinase inhibitor (multikinase inhibitor).

Nexavar was first approved by the FDA in 2005 and is manufactured by Bayer Healthcare. A generic product for Nexavar is now available, which may make this medicine more affordable.

Is Nexavar a chemotherapy drug?

Nexavar (sorafenib) is not a traditional chemotherapy drug but it is used to treat cancer. It is considered a targeted drug therapy and is given by mouth as an oral tablet.

Nexavar is classified as a tyrosine kinase inhibitor (TKI) and VEGF inhibitor (angiogenesis inhibitor). It is approved by the FDA to treat liver cancer, thyroid cancer and kidney cancer.

Does Nexavar cause hair loss?

Like many drugs used to treat cancer, Nexavar has been reported to cause patchy hair loss (alopecia) or hair thinning in 14% to 67% of patients. Hair loss or hair thinning is one of the more common side effects with Nexavar. The highest rates of alopecia have occurred in thyroid cancer studies.

Alopecia, or hair thinning or loss, is a side effect that can occur with many different cancer treatments but is usually reversible when treatment stops. Some people may not have significant hair loss, while for others it may be more noticeable. Sometimes hair may grow back a different texture (more curly) or slightly changed color.

Hair loss can be a distressing side effect for many patients, but there are ways to minimize this.

Related: Common Side Effects and Warnings with Nexavar (in more detail)

Always consult with your doctor and cancer-care team about any medication side effects during your cancer treatment.

This is not all the information you need to know about Nexavar (sorafenib) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

Related questions

References

Read next

What is the success rate of Keytruda?

In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading

How long does it take for Keytruda to work?

The time it takes for Keytruda to work can vary based on the type and stage of cancer. Typically, a response to treatment becomes apparent within 2-4 months of starting Keytruda. This timeframe is referred to as "time to response," which measures when a patient's cancer begins to show signs of responding to the treatment. You can find the specific "time to response" data from clinical trials in the table below. Continue reading

What is the difference between Opdivo and Keytruda?

Opdivo (nivolumab) and Keytruda (pembrolizumab) are two immunotherapy drugs for various cancers. Both are monoclonal antibodies, known as PD1 inhibitors, first approved in 2014. Opdivo is from Bristol Myers Squibb, and Keytruda is from Merck & Co. The main differences lie in dosing, combination therapies, and approved cancer types. Continue reading

See also:

Related medical questions

Drug information

Related support groups